BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16734113)

  • 1. The effect of chemical inactivation of bovine viral diarrhea virus with beta-propiolactone and binary ethyleneimine on plasma proteins and coagulation factors.
    Refaie FM; Esmat AY; Mohamed AF; Mohamed WA
    Egypt J Immunol; 2004; 11(2):9-20. PubMed ID: 16734113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of viruses by beta-propiolactone in human cryo poor plasma and IgG concentrates.
    Scheidler A; Rokos K; Reuter T; Ebermann R; Pauli G
    Biologicals; 1998 Jun; 26(2):135-44. PubMed ID: 9811521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Three Types of Inactivation Agents on the Antibody Response and Immune Protection of Inactivated IHNV Vaccine in Rainbow Trout.
    Tang L; Kang H; Duan K; Guo M; Lian G; Wu Y; Li Y; Gao S; Jiang Y; Yin J; Liu M
    Viral Immunol; 2016 Sep; 29(7):430-5. PubMed ID: 27548006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus.
    Sasaki Y; Yoshino N; Sato S; Muraki Y
    J Virol Methods; 2016 Sep; 235():105-111. PubMed ID: 27142111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multistep procedure for the chemical inactivation of human immunodeficiency virus for use as an experimental vaccine.
    Race E; Stein CA; Wigg MD; Baksh A; Addawe M; Frezza P; Oxford JS
    Vaccine; 1995 Nov; 13(16):1567-75. PubMed ID: 8578844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of binary ethyleneimine (BEI) used as an inactivant for foot and mouth disease tissue culture vaccine.
    Aarthi D; Ananda Rao K; Robinson R; Srinivasan VA
    Biologicals; 2004 Sep; 32(3):153-6. PubMed ID: 15536046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus.
    Kamaraj G; Lakshmi Narasu M; Srinivasan VA
    Res Vet Sci; 2008 Dec; 85(3):589-94. PubMed ID: 18262212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the effect of chemical inactivants on the epitopes of Rift Valley fever virus glycoproteins using monoclonal antibodies.
    Blackburn NK; Besselaar TG
    J Virol Methods; 1991 Aug; 33(3):367-74. PubMed ID: 1723736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids.
    Fan C; Ye X; Ku Z; Kong L; Liu Q; Xu C; Cong Y; Huang Z
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation by polymerase chain reaction on the effect of beta-propiolactone and binary ethyleneimine on DNA.
    Groseil C; Guerin P; Adamowicz P
    Biologicals; 1995 Sep; 23(3):213-20. PubMed ID: 8527120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production.
    Mondal SK; Neelima M; Seetha Rama Reddy K; Ananda Rao K; Srinivasan VA
    Biologicals; 2005 Sep; 33(3):185-9. PubMed ID: 16084736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential.
    Gupta D; Parthasarathy H; Sah V; Tandel D; Vedagiri D; Reddy S; Harshan KH
    Virus Res; 2021 Nov; 305():198555. PubMed ID: 34487766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of influenza virus with beta-propiolactone alters viral membrane fusion.
    Bonnafous P; Nicolaï MC; Taveau JC; Chevalier M; Barrière F; Medina J; Le Bihan O; Adam O; Ronzon F; Lambert O
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):355-63. PubMed ID: 24140008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood products.
    Steinmann E; Gravemann U; Friesland M; Doerrbecker J; Müller TH; Pietschmann T; Seltsam A
    Transfusion; 2013 May; 53(5):1010-8. PubMed ID: 22905868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines.
    Pollock RV; Carmichael LE
    Cornell Vet; 1982 Jan; 72(1):16-35. PubMed ID: 6279359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates.
    Beutgen VM; Bhagwat AM; Steitz AM; Reinartz S; Müller R; Graumann J
    Anal Chem; 2024 Jun; 96(23):9332-9342. PubMed ID: 38810147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum.
    King DJ
    Avian Dis; 1991; 35(3):505-14. PubMed ID: 1835374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of riboflavin photochemical-mediated virus inactivation and changes in protein retention in fresh-frozen plasma treated using a flow-based treatment device.
    Zhu L; Pan J; Wei C; Wang H; Xiang R; Zhang J; Wang D
    Transfusion; 2015 Jan; 55(1):100-7. PubMed ID: 25070346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of DNA by beta-propiolactone.
    Perrin P; Morgeaux S
    Biologicals; 1995 Sep; 23(3):207-11. PubMed ID: 8527119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trials for preparation of inactivated sheep pox vaccine using binary ethyleneimine.
    Awad M; Michael A; Soliman SM; Samir SS; Daoud AM
    Egypt J Immunol; 2003; 10(2):67-72. PubMed ID: 15719613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.